cyanovirinn
cvn
promis
antivir
candid
extrem
low
sequenc
homolog
known
protein
effici
solubl
express
biolog
function
recombin
cvn
rcvn
still
obstacl
due
insuffici
yield
aggreg
abnorm
modif
describ
improv
approach
prepar
nativ
rcvn
escherichia
coli
effici
fusion
gene
consist
cvn
sumo
small
ubiquitinrel
modifi
hexahistidin
tag
construct
accord
codon
bia
host
cell
small
ubiquitinrel
modifi
sumo
fuse
cvn
express
cytoplasm
e
coli
fold
solubl
form
total
solubl
protein
yield
mg
nativ
rcvn
g
wet
cell
puriti
matrixassist
laser
desorpt
ioniz
coupl
timeofflight
mass
spectrometri
reversephas
highperform
liquid
chromatograph
analysi
show
purifi
rcvn
intact
homogen
protein
molecular
weight
da
potent
antivir
activ
rcvn
herp
simplex
viru
type
human
immunodefici
viru
type
confirm
dosedepend
manner
nanomolar
concentr
thu
hissumo
doublefus
cvn
provid
effici
approach
solubl
express
rcvn
cytoplasm
e
coli
allow
altern
system
develop
bioprocess
largescal
product
antivir
candid
human
immunodefici
viru
hiv
remain
global
health
problem
unpreced
dimens
global
estim
million
peopl
live
hiv
unaid
cyanovirinn
cvn
potent
antihiv
protein
shown
promis
vivo
efficaci
recent
buffa
et
al
tsai
et
al
origin
discov
isol
aqueou
extract
cyanobacterium
bluegreen
alga
nostoc
ellipsosporum
boyd
et
al
cvn
perman
effici
inactiv
extens
rang
hiv
strain
well
prevent
celltocel
fusion
transmiss
hiv
act
bind
high
affin
nlink
highmannos
glycan
present
dey
et
al
shenoy
et
al
thu
inhibit
attach
fusion
viru
particl
target
cell
addit
cvn
also
activ
rhinovirus
herp
simplex
viru
type
hepat
c
ebola
viru
influenza
b
virus
barriento
et
al
hell
et
al
okeef
et
al
smee
et
al
furthermor
cvn
insensit
denatur
deterg
organ
solvent
extrem
temperatur
potent
hivinactiv
abil
cvn
physicochem
properti
make
protein
suitabl
use
topic
antihiv
drug
cvn
uniqu
sequenc
amino
acid
residu
boyd
et
al
although
two
halv
residu
monomer
cvn
share
high
degre
sequenc
homolog
cvn
extrem
low
sequenc
homolog
known
protein
homolog
greater
eight
contigu
amino
acid
total
sequenc
known
protein
addit
contain
two
intramolecular
disulfid
bond
bewley
et
al
yang
et
al
properti
make
artifici
product
protein
difficult
express
recombin
cvn
rcvn
attempt
variou
speci
includ
escherichia
coli
boyd
et
al
colleluori
et
al
mori
et
al
pichia
pastori
mori
et
al
transgen
nicotiana
tabacum
sexton
et
al
effici
express
biolog
function
rcvn
still
problemat
due
low
yield
aggreg
abnorm
modif
thu
far
e
coli
still
consid
simplest
effici
least
expens
host
produc
simpl
protein
rcvn
liu
schultz
howev
complex
reductas
system
cytoplasm
e
coli
render
difficult
form
stabl
disulfid
bond
prinz
et
al
crucial
bioactiv
cvn
periplasm
feasibl
locat
format
disulfid
bond
protein
refold
yield
extrem
low
usual
less
mgl
heterolog
protein
produc
periplasm
mergulhao
et
al
addit
express
periplasm
lead
ompa
signal
peptid
final
rcvn
product
mixtur
intact
protein
truncat
product
miss
first
two
ntermin
residu
mori
et
al
prinz
et
al
altern
express
cvn
inclus
bodi
cytoplasm
increas
yield
mg
rcvng
wet
cell
nevertheless
express
remain
problemat
method
produc
signific
fraction
dimer
speci
consist
well
gener
uncharacter
sidechain
modif
colleluori
et
al
small
ubiquitinrel
modifi
sumo
famili
protein
function
posttransl
modifi
attach
protein
coval
revers
saitoh
hinchey
recent
sumo
fuse
nterminu
heterolog
protein
found
improv
protein
fold
enhanc
express
level
protect
protein
degrad
via
properti
chaperonin
sumofus
protein
specif
cleav
sumo
proteas
depend
structur
sumo
tag
fusion
site
target
protein
releas
togeth
nativ
n
terminu
malakhov
et
al
recent
seri
sumo
express
vector
develop
effici
product
recombin
protein
prokaryot
eukaryot
host
cell
assadiport
et
al
liu
et
al
sun
et
al
ye
et
al
test
effect
saccharomyc
cerevisia
express
rcvn
cytoplasm
e
coli
use
construct
carri
sumofus
cvn
hexahistidin
tag
found
new
system
produc
solubl
biolog
function
rcvn
effici
cytoplasm
e
coli
could
rapidli
purifi
intact
homolog
nativ
rcvn
two
round
ni
chelat
chromatographi
interven
sumo
proteas
cleavag
step
low
cost
reduc
time
consumpt
improv
system
make
suitabl
largescal
product
rcvn
gene
splice
overlap
extens
standard
overlap
extens
carri
use
pmol
primer
ng
templat
u
pyrobest
dna
polymeras
invitrogen
carlsbad
ca
usa
reagent
per
manufactur
instruct
amplif
cycl
consist
denatur
min
anneal
elong
min
horton
et
al
dna
sequenc
encod
sumo
amplifi
vector
petsumo
use
forward
primer
fsumo
revers
primer
rsumo
ccaagaccaccaatctgtt
result
fragment
splice
encod
sequenc
cvn
primer
fsumo
g
g
g
c
c
c
c
c
g
tat
c
g
g
gtaccgtcgatgttagcgatgtggtc
open
read
frame
orf
bp
digest
ndei
bamhi
takara
dalian
china
follow
subclon
novagen
creat
correspond
express
plasmid
petsumocvn
transform
e
coli
invitrogen
sequenc
correct
insert
time
anoth
express
plasmid
petcvn
without
sumo
also
construct
use
vector
site
fragment
dna
recombin
purifi
use
agaros
gel
electrophoresi
gel
recoveri
kit
sangon
shanghai
china
individu
coloni
e
coli
novagen
madison
wi
usa
harbor
petsumocvn
petcvn
plasmid
inocul
luriabertani
lb
medium
contain
ampicillin
optim
condit
glucos
mm
mgso
ad
medium
cell
grown
shake
incub
rpm
cultur
reach
od
point
mm
isopropylbetadthiogalactopyranosid
iptg
ad
cell
grown
h
induct
cell
harvest
centrifug
min
lyse
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
load
buffer
analysi
determin
solubl
recombin
sumocvn
rcvn
cell
ml
induc
cultur
freezethaw
thoroughli
resuspend
buffer
mm
trishcl
ph
moll
nacl
mm
imidazol
ratio
g
cell
ml
buffer
follow
addit
gl
lysozym
dingguo
china
incub
min
whole
cell
lysat
centrifug
min
separ
solubl
insolubl
fraction
typic
procedur
purif
nativ
rcvn
illustr
fig
hexahistidinetag
sumocvn
e
coli
initi
purifi
ion
metal
affin
chromatographi
ninta
agaros
ge
healthcar
usa
fifti
millilit
clear
bacteri
lysat
l
lb
cultur
appli
xk
column
ge
healthcar
usa
contain
ml
ninta
resin
equilibr
ten
column
volum
buffer
resin
wash
buffer
od
reach
base
line
nonspecif
bound
protein
elut
ml
buffer
mm
trishcl
ph
nacl
mm
imidazol
final
recombin
hexahistidinetag
sumocvn
elut
buffer
mm
trishcl
ph
moll
nacl
mm
imidazol
appli
sephadex
column
ge
healthcar
usa
wash
buffer
mm
trishcl
ph
igep
nacl
mm
dithiothreitol
remov
imidazol
elut
sumocvn
digest
sumo
proteas
u
enzym
substrat
h
ninta
column
use
remov
sumo
undigest
sumocvn
sumo
proteas
hexahistidin
tag
also
fuse
ntermin
thu
result
nativ
rcvn
puriti
rcvn
analyz
reduc
tristricin
sdspage
gel
protein
concentr
determin
use
bradford
method
bradford
purifi
nativ
rcvn
subject
matrixassist
laser
desorpt
ioniz
coupl
timeofflight
mass
spectrometri
malditof
ms
confirm
peptid
mass
map
molecular
weight
mw
henzel
et
al
briefli
separ
tristricin
sdspage
gel
follow
silver
stain
rcvn
band
excis
destain
potassium
ferricyanid
sodium
thiosulf
protein
ingel
digest
gl
trypsin
overnight
digest
peptid
extract
load
onto
mtp
anchorchip
tm
tf
brukerdaltonik
bremen
germani
malditof
ms
analysi
carri
use
ultraflex
tm
malditof
mass
spectromet
brukerdaltonik
molecular
weight
determin
purifi
protein
load
directli
onto
palladium
plate
analyz
ultraflex
tm
malditof
mass
spectromet
puriti
purifi
rcvn
confirm
use
reversephas
highperform
liquid
chromatographi
rphplc
addit
sdspage
analysi
sampl
load
onto
zorbax
column
agil
lifesci
usa
elut
linear
gradient
acetonitril
flow
rate
mlmin
presenc
trifluoroacet
acid
hplc
system
agil
lifesci
model
usa
configur
quarter
pump
diod
array
detector
activ
rcvn
determin
use
tetrazolium
bromid
mtt
method
takeuchi
et
al
briefli
rcvn
twofold
serial
dilut
nm
nm
dilut
tcid
state
key
laboratori
virolog
wuhan
univers
china
ad
monolay
vero
cell
atcc
usa
microtit
plate
cytotox
determin
simultan
carri
well
test
sampl
without
viru
concurr
acyclovir
use
posit
control
incub
co
h
mtt
reagent
ad
color
develop
absorb
measur
use
micropl
reader
biorad
laboratori
usa
inhibit
concentr
ic
cytotox
concentr
cc
calcul
antihiv
activ
recombin
cvn
determin
vitro
use
watersolubl
tetrazolium
salt
wst
method
laboratori
boyd
et
al
duewek
et
al
cvn
twofold
serial
dilut
rapid
prototyp
manufactur
institut
medium
invitrogen
contain
fetal
bovin
serum
dilut
tcid
harvest
cultur
supernat
iiib
cell
ad
cell
well
microtit
plate
final
concentr
cvn
rang
nm
time
azidothymidin
azt
sigma
rang
nm
use
posit
control
incub
co
h
ad
develop
color
absorb
determin
use
micropl
reader
wako
japan
evalu
activ
sampl
test
triplic
reproduc
confirm
three
separ
experi
gel
electrophoresi
sdspage
tricin
sdspage
carri
reduc
condit
previous
describ
laemmli
gel
scan
densitomet
biorad
usa
stain
coomassi
blue
express
level
rcvn
determin
artifici
code
sequenc
cvn
design
de
novo
nine
oligo
synthes
overlap
fig
sequenc
hissumo
amplifi
use
primer
pair
sequenc
code
hexahistidin
ad
forward
primer
final
product
multipl
overlap
extens
clone
ndei
bamhi
restrict
site
get
express
plasmid
petsumocvn
transform
express
host
e
coli
protein
express
h
induct
mm
iptg
sumocvn
effici
express
cytoplasm
e
coli
total
protein
fig
almost
target
protein
found
supernat
total
solubl
protein
suggest
protein
quit
solubl
contrast
express
rcvn
without
sumo
fusion
vector
host
cell
detect
fig
similar
result
also
obtain
use
sumoneg
cvn
variou
e
coli
strain
includ
origami
data
shown
express
vector
strong
promot
success
use
express
hndpka
previous
xiong
et
al
also
test
possibl
express
sumoneg
rcvn
periplasm
e
coli
instead
cytoplasm
still
found
visibl
express
thu
show
first
time
sumo
effect
stabil
facilit
solubl
express
rcvn
cytoplasm
e
coli
purif
nativ
rcvn
sumocvn
fusion
protein
first
optim
express
condit
target
protein
e
coli
test
variou
cultur
temperatur
induct
period
iptg
concentr
fig
signific
differ
express
target
protein
found
either
mm
iptg
use
induct
cultur
induc
h
express
sumocvn
increas
gradual
increas
temperatur
longer
induct
period
h
increas
express
level
highest
express
level
obtain
cultur
induc
mm
iptg
h
optimum
condit
express
level
total
protein
induct
iptg
optimum
condit
total
solubl
protein
extract
appli
ninta
column
wash
buffer
contain
mm
imidazol
sumocvn
subsequ
elut
puriti
fig
digest
sumo
proteas
releas
nativ
rcvn
protein
run
cleav
protein
ninta
column
captur
hexahistidinetag
protein
nativ
rcvn
could
separ
sumo
undigest
sumocvn
sumo
proteas
approxim
mg
nativ
rcvn
could
purifi
g
wet
cell
use
process
puriti
demonstr
consider
amount
nativ
rcvn
protein
could
easili
econom
purifi
system
make
suitabl
futur
largescal
product
protein
addit
format
inclus
bodi
unresolv
problem
express
rcvn
e
coli
includ
ntermin
delet
dimer
sidechain
modif
result
differ
appar
mw
final
recombin
product
mori
et
al
confirm
structur
integr
rcvn
express
system
determin
mw
purifi
rcvn
use
malditof
ms
found
mw
rcvn
da
agreement
theoret
mw
natur
cvn
fig
eight
known
trypsin
cleavag
site
natur
cvn
make
possibl
confirm
sequenc
ident
rcvn
product
determin
peptid
profil
rcvn
peptid
mass
fingerprint
pmf
analysi
predict
cleavag
map
natur
cvn
shown
fig
malditoftof
ms
spectra
ingel
digest
rcvn
fig
six
peptid
fragment
molecular
weight
compar
natur
counterpart
identifi
databas
interpret
also
confirm
ident
rcvn
puriti
anoth
import
characterist
recombin
drug
candid
addit
sdspage
analysi
fig
rphplc
also
employ
determin
puriti
final
product
figur
show
elut
profil
rcvn
column
smooth
gaussian
curv
without
shoulder
peak
taken
togeth
result
provid
evid
sumo
express
system
use
abl
produc
highqual
rcvn
final
examin
biolog
activ
purifi
rcvn
use
rna
viru
b
dna
viru
model
evalu
antivir
activ
rcvn
assay
reveal
nativ
rcvn
possess
signific
antivir
activ
ic
cc
nm
respect
tabl
concentr
nm
inhibit
rate
rcvn
respect
control
azt
wellknown
antihiv
compound
exhibit
inhibit
viru
concentr
nm
fig
ic
rcvn
nm
cc
nm
tabl
result
indic
purifi
rcvn
function
activ
addit
sumocvn
also
exhibit
activ
ic
nm
compar
nativ
rcvn
result
serv
evid
sumocvn
produc
cytoplasm
fulli
fold
biolog
function
form
provid
altern
sourc
protein
practic
applic
largescal
product
rcvn
potenti
antivir
drug
use
genet
engin
microorgan
requir
provid
readi
sourc
materi
practic
applic
fischetti
et
al
sexton
et
al
howev
sequenc
properti
cvn
make
difficult
produc
heterolog
host
express
rcvn
transgen
plant
timeconsum
low
yield
undevelop
downstream
process
potenti
posttransl
modif
sexton
et
al
anoth
choic
produc
rcvn
differ
eukaryot
system
p
pastori
howev
seem
difficult
obtain
nativ
rcvn
use
system
highmannos
nglycosyl
posit
dimer
final
product
mediat
hing
region
result
loss
antivir
activ
rcvn
mori
et
al
although
e
coli
far
beststudi
host
consider
problem
still
exist
practic
use
express
rcvn
low
protein
yield
remain
major
issu
addit
rcvn
express
e
coli
tend
aggreg
nonfunct
form
attribut
lack
stabl
disulfid
bond
format
proper
fold
attempt
solv
problem
fuse
cvn
yeast
preced
hexahistidin
tag
studi
effici
system
express
rcvn
e
coli
sumo
common
protein
eukaryot
cell
regul
activ
cellular
local
target
protein
modif
process
similar
ubiquitin
kim
et
al
sever
protein
difficult
express
convent
system
sarscov
structur
protein
zuo
et
al
metalloproteas
marbleston
et
al
brazzein
assadiport
et
al
urodilatin
antibodi
fragment
ye
et
al
success
express
e
coli
use
sumo
fusion
strategi
data
show
sumocvn
fusion
construct
effici
express
solubl
form
cytoplasm
e
coli
support
idea
sumo
facilit
solubl
express
foreign
heterolog
protein
e
coli
sumo
fusion
label
mechan
yield
enhanc
solubl
improv
still
unclear
sever
studi
implic
may
function
chaperonin
act
core
fold
recombin
protein
e
coli
specif
affin
method
avail
nativ
cvn
usual
isol
gener
chromatographi
techniqu
rphplc
anion
exchang
ni
affin
chromatographi
also
appli
rapidli
purifi
rcvn
produc
p
pastori
mori
et
al
final
product
histag
rather
nativ
rcvn
possibl
releas
nativ
rcvn
sumocvn
cleav
sumo
proteas
site
fusion
advantag
system
hexahistidin
tag
fuse
ntermin
sumo
sumocvn
could
rapidli
purifi
total
protein
extract
simpli
run
ninta
column
digest
sumo
proteas
releas
nativ
rcvn
could
subsequ
purifi
use
column
puriti
purif
process
obtain
final
yield
mgg
wet
cell
amount
consider
protein
induc
e
coli
convent
flaskshak
cultur
e
coli
cultur
densiti
greater
g
dcwl
optim
condit
lee
xia
et
al
ordinari
fermentor
cultur
biomass
g
wcwl
level
usual
reach
laboratori
xiong
et
al
yield
rcvn
sumo
cvn
system
fermentor
fedbatch
cultur
therefor
expect
mgl
effort
made
improv
protein
yield
nativ
rcvn
use
system
express
solubl
sumocvn
major
advantag
express
system
highest
yield
rcvn
report
thu
far
mgl
achiev
use
fermentor
cultur
colleluori
et
al
howev
protein
express
inclus
bodi
dramat
decreas
protein
qualiti
problem
report
rcvn
express
e
coli
includ
ntermin
delet
dimer
sidechain
modif
mw
determin
pmf
analysi
rphplc
chromatographi
sdspage
demonstr
purifi
rcvn
deriv
system
intact
homogen
monomer
anoth
advantag
system
intermedi
recombin
product
sumocvn
also
biolog
function
antivir
activ
hsv
compar
nativ
rcvn
result
demonstr
sumocvn
produc
cytoplasm
e
coli
fulli
fold
function
form
provid
altern
sourc
practic
applic
compar
ic
cc
rcvn
natur
one
boyd
et
al
look
like
rcvn
potent
natur
product
ic
report
signific
higher
previou
report
nm
might
result
differ
bioassay
paramet
host
cell
origin
viru
titer
detect
system
trace
impur
recombin
product
data
commerci
azt
also
display
higher
ic
previou
report
nm
mitsuya
et
al
suggest
system
differ
bioassay
method
cvn
promis
candid
topic
hiv
microbicid
dose
prove
effect
macaqu
studi
requir
product
capac
kg
year
suppli
ten
million
women
twice
week
shattock
moor
scale
protein
product
may
achiev
express
system
could
produc
rcvn
high
product
low
cost
propos
improv
approach
effici
express
rcvn
cytoplasm
e
coli
fuse
rcvn
sumo
effici
produc
cytoplasm
e
coli
level
total
solubl
protein
addit
hexahistidin
tag
fuse
ntermin
sumo
intact
nativ
rcvn
rapidli
purifi
solubl
biolog
activ
form
improv
still
requir
eventu
bring
promis
antivir
candid
bench
clinic
applic
